21 – 30 of 162
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease
(
- Contribution to journal › Article
- 2019
-
Mark
Midregional proadrenomedullin predicts reduced blood pressure and glucose elevation over time despite enhanced progression of obesity markers
(
- Contribution to journal › Article
-
Mark
Blood glucose and hypertension development : the hen and egg controversy
(
- Contribution to journal › Article
- 2018
-
Mark
Characteristics of healthy vascular ageing in pooled population-based cohort studies : the global Metabolic syndrome and Artery REsearch Consortium
(
- Contribution to journal › Article
- 2016
-
Mark
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.
(
- Contribution to journal › Letter
-
Mark
A stop-codon of the phosphodiesterase 11A gene is associated with elevated blood pressure and measures of obesity.
(
- Contribution to journal › Article
-
Mark
DPP-4 inhibition and blood pressure lowering in perspective.
(
- Contribution to journal › Article
- 2015
-
Mark
Pulse wave velocity distribution in a cohort study: from arterial stiffness to early vascular aging.
(
- Contribution to journal › Article
-
Mark
Joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and early vascular ageing.
(
- Contribution to journal › Article
-
Mark
New developments in the pathogenesis of obesity-induced hypertension.
(
- Contribution to journal › Article